Issue 1/2020
Content (24 Articles)
Impact of NR5A2 and RYR2 3′UTR polymorphisms on the risk of breast cancer in a Chinese Han population
Ying Wei, Xiaolin Wang, Zhe Zhang, Changtao Zhao, Yuwei Chang, Zhiqing Bian, Xinhan Zhao
A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer
Rachel Starkings, Valerie Shilling, Valerie Jenkins, Lesley Fallowfield
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
Michelle D. Hackshaw, Heather E. Danysh, Jasmeet Singh, Mary E. Ritchey, Amy Ladner, Corina Taitt, D. Ross Camidge, Hiroji Iwata, Charles A. Powell
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer
Yoshiya Horimoto, Noriko Sasahara, Ritsuko Sasaki, May Thinzar Hlaing, Asumi Sakaguchi, Harumi Saeki, Atsushi Arakawa, Takanori Himuro, Mitsue Saito
Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
Rashmi Verma, Andrew M. Hanby, Kieran Horgan, Eldo T. Verghese, Milene Volpato, Clive R. Carter, Thomas A. Hughes
Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer
Fang-Ming Chen, Li-Ju Huang, Fu Ou-Yang, Jung-Yu Kan, Li-Chun Kao, Ming-Feng Hou
CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA
Xiaowei Yang, Lu Zhao, Jing Pei, Zhaorui Wang, Jingjie Zhang, Benzhong Wang
Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema
Paula M. C. Donahue, Rachelle Crescenzi, Chelsea Lee, Maria Garza, Niral J. Patel, Kalen J. Petersen, Manus J. Donahue
Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers
Dingxie Liu
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
Ahrong Ham, Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joohyuk Sohn
Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study
Hadeer G. Khalefa, May A. Shawki, Rasha Aboelhassan, Lamia M. El Wakeel
Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy
George E. Naoum, Oluwadamilola T. Oladeru, Andrzej Niemierko, Laura Salama, Jonathan Winograd, Amy Colwell, Waleed O. Arafat, Barbara Smith, Alice Ho, Alphonse G. Taghian
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
Vincent Walter, Chiara Fischer, Thomas M. Deutsch, Catherine Ersing, Juliane Nees, Florian Schütz, Carlo Fremd, Eva-Maria Grischke, Peter Sinn, Sara Y. Brucker, Andreas Schneeweiss, Andreas D. Hartkopf, Markus Wallwiener
Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery
Elyse LeeVan, Be Thi Ho, Sadie Seto, Jeannie Shen
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
Sixten Harborg, Uffe Heide-Jørgensen, Thomas P. Ahern, Marianne Ewertz, Deirdre Cronin-Fenton, Signe Borgquist
Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score
Stephanie Robertson, Balazs Acs, Michael Lippert, Johan Hartman
Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study
Lidia Staszewsky, Fabio Robusto, Vito Lepore, Lucia Bisceglia, Vito Petrarolo, Antonio D’Ettorre, Gianni Tognoni, Roberto Latini
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management
Marianna Cavazza, Helen Banks, Michele Ercolanoni, Gjiliola Cukaj, Giulia Bianchi, Giuseppe Capri, Francesco Longo
Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data
Melissa K. Accordino, Jason D. Wright, Donna Buono, Aijing Lin, Yongmei Huang, Alfred I. Neugut, Grace C. Hillyer, Dawn L. Hershman
Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China
Jing Yao, Yanfang Liu, Jing Cheng
Association between selenium intake and breast cancer risk: results from the Women’s Health Initiative
Dan Guo, Michael Hendryx, Xiaoyun Liang, JoAnn E. Manson, Ka He, Mara Z. Vitolins, Yueyao Li, Juhua Luo
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer
Diana G. Wang, Dulce M. Barrios, Victoria S. Blinder, Jacqueline F. Bromberg, Pamela R. Drullinsky, Samuel A. Funt, Komal L. Jhaveri, Diana E. Lake, Tomas Lyons, Shanu Modi, Pedram Razavi, Michelle Sidel, Tiffany A. Traina, Linda T. Vahdat, Mario E. Lacouture
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer
Marta Perachino, Francesca Poggio, Matteo Lambertini
A case for Tamoxifen with ovarian function suppression
Pallavi Kopparthy, Karen Daily